{"brief_title": "An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)", "brief_summary": "The purpose of this study is to determine the safety and effectiveness of an investigational drug in patients with Type 2 Diabetes Mellitus.", "condition": "Diabetes Mellitus, Type 2", "intervention_type": "Drug", "intervention_name": "Comparator: pioglitazone", "description": "pioglitazone 30 mg oral tablet once daily during Phase B (Weeks 18-54)", "arm_group_label": "Placebo/Pioglitazone", "criteria": "Inclusion Criteria: - Patients at least 18 years of age and not older than 75 who have a specific type of diabetes called Type 2 Diabetes Mellitus Exclusion Criteria: - Younger than 18 years of age or older than 75 - Any condition, which in the opinion of the investigator, may not be in the patient's best interest to participate", "gender": "All", "minimum_age": "18 Years", "maximum_age": "75 Years", "healthy_volunteers": "No", "id": "NCT00094757.xml"}